Reduction in emergency room visits with cenobamate in pharmaco-resistant epilepsy: an observational study
Objective: Cenobamate (Xcopri) is an antiepileptic drug introduced in Israel in July 2023 that has shown promise in reducing seizure frequency in patients with focal seizures.This study aims to evaluate the real-world effectiveness and safety of Cenobamate in a clinical setting, providing insights i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Brain Disorders |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666459325000435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|